Ever since the coronavirus pandemic brought the world to a standstill back in March, there’s been talk of a vaccine. COVID-19 vaccines have been badged as our biggest opportunity to control the virus and return to normal. And for the last 10 months, researchers and scientists across the world have been racing to make that a reality. Read More…
The death rate from cancer in the U.S. dropped 2.4% from 2017 to 2018, the biggest single-year decline on record and a sign of the impact of new treatments on lung cancer especially, the American Cancer Society said. Read More…
Roughly 5 to 10 percent of all colorectal cancers (CRCs) are considered hereditary and result from mutations and defects in specific genes. Another 25 to 30 percent of patients with CRC may have a family member with a diagnosis of CRC but no known genetic alterations. Read More…
Hereditary causes, due to defects in certain genes, account for up to 10% of all colorectal cancers (CRCs). These high-risk hereditary predisposition syndromes have been associated with a significantly increased lifetime risk of cancer, with some approaching 100%. In addition, up to 20% of patients with CRC have common familial cancer, meaning Read more…
In a sea of new multiple myeloma treatment options, Shaji Kumar, M.D., hematologist at Mayo Clinic in Rochester, Minnesota, recommends taking the long view: Both initial and subsequent treatments should be selected bearing in mind what may be coming in the future for the patient’s disease. In presentations at the National Read more…
Implementing policies and strategies to eliminate racial disparities could improve outcomes for both diseases Income level, employment, housing location, medical insurance, education, tobacco and alcohol use, diet and obesity, access to medical care. These are some of the factors causing worse cancer outcomes in people who are Black. Read More…
In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of Read more…
The type and abundance of bacteria found in the mouth may be linked to lung cancer risk in non-smokers, finds the first study of its kind, published online in the journal Thorax. Read More…
A comprehensive study from Uppsala University, involving more than 250,000 women, shows that oral contraceptive use protects against ovarian and endometrial cancer. The protective effect remains for several decades after discontinuing the use. The study is published in the journal Cancer Research. Read More…
Relative to the previous standard of sunitinib, a combination of the checkpoint inhibitor nivolumab and the tyrosine kinase inhibitor cabozantinib improve overall survival (OS) in patients with advanced renal cell carcinoma (RCC), according to results from the phase 3 CheckMate 9ER trial. Although not the only combination strategy to show Read more…